What is Zevra Therapeutics, Inc.'s warrant liability?

Zevra Therapeutics, Inc. (ZVRA) reported warrant liability of $6.8M in Q1 2026.

How has Zevra Therapeutics, Inc.'s warrant liability changed year-over-year?

Zevra Therapeutics, Inc.'s warrant liability decreased by 47.8% year-over-year, from $13.03M to $6.8M.

What is the long-term trend for Zevra Therapeutics, Inc.'s warrant liability?

Over 3 years (2022 to 2025), Zevra Therapeutics, Inc.'s warrant liability has grown at a -2.1% compound annual growth rate (CAGR), from $10.2M to $9.58M.

Zevra Therapeutics, Inc. ZVRA Warrant liability

Other financials

Income statement

See full

Revenue$36.2M+77.5%

Gross profit$34.3M+80.1%

Operating income$52.1M+1,073%

Net income$37.9M+1,323%

EPS (diluted)$0.60+1,100%

Balance sheet

See full

Cash & equivalents$95.6M+156%

Total debt$1.1M-98.1%

Total equity$205.8M+402%

Total assets$278.6M+61.3%

Cash flow

See full

Operating cash flow$6.1M+175%

CapEx$35.0K-64.6%

Free cash flow$6.1M+173%

Valuation

See full

Market cap$782.09M+58.2%

Enterprise value$687.64M+32.5%

P/E6.3×—

P/S6.4×-5.8×

Profitability

See full

Gross margin86.1%+7.2pp

Operating margin-103.9%-43.0pp

Net margin101.6%+60.1pp

FCF margin-75%-30.5pp

Returns & leverage

See full

Return on equity100.7%+60.3pp

Debt / equity0×-1.5×

Current ratio4.9×+1.9×

Where this comes from

Reported directly by Zevra Therapeutics, Inc. in its filing.

Tagged under the XBRL concept zvra:DerivativeAndWarrantLiabilityNoncurrent.

The official record: Zevra Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zevra Therapeutics, Inc.'s warrant liability.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Zevra Therapeutics, Inc.'s warrant liability?: Zevra Therapeutics, Inc. (ZVRA) reported warrant liability of $6.8M in Q1 2026.
How has Zevra Therapeutics, Inc.'s warrant liability changed year-over-year?: Zevra Therapeutics, Inc.'s warrant liability decreased by 47.8% year-over-year, from $13.03M to $6.8M.
What is the long-term trend for Zevra Therapeutics, Inc.'s warrant liability?: Over 3 years (2022 to 2025), Zevra Therapeutics, Inc.'s warrant liability has grown at a -2.1% compound annual growth rate (CAGR), from $10.2M to $9.58M.